These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 35899276)
1. Comparison of Sequential Dalbavancin With Standard-of-Care Treatment for Molina KC; Lunowa C; Lebin M; Segerstrom Nunez A; Azimi SF; Krsak M; Mueller SW; Miller MA Open Forum Infect Dis; 2022 Jul; 9(7):ofac335. PubMed ID: 35899276 [TBL] [Abstract][Full Text] [Related]
2. Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections. Veve MP; Patel N; Smith ZA; Yeager SD; Wright LR; Shorman MA Int J Antimicrob Agents; 2020 Dec; 56(6):106210. PubMed ID: 33223119 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology of bloodstream infections caused by methicillin-resistant Staphylococcus aureus at a tertiary care hospital in New York. Yasmin M; El Hage H; Obeid R; El Haddad H; Zaarour M; Khalil A Am J Infect Control; 2016 Jan; 44(1):41-6. PubMed ID: 26412481 [TBL] [Abstract][Full Text] [Related]
5. Dalbavancin vs standard of care for Staphylococcus aureus bacteraemia in patients unable to receive outpatient parenteral antimicrobial therapy. Frazier JD; Stoudenmire LL; Wagner JL; Thomas GM; Steele GM; Henao-Martínez AF; Franco-Paredes C; Chastain DB Int J Antimicrob Agents; 2023 Jul; 62(1):106842. PubMed ID: 37160242 [TBL] [Abstract][Full Text] [Related]
6. Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care. Johnson TM; Molina KC; Miller MA; Kiser TH; Huang M; Mueller SW Int J Antimicrob Agents; 2021 Apr; 57(4):106310. PubMed ID: 33609718 [TBL] [Abstract][Full Text] [Related]
7. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221 [TBL] [Abstract][Full Text] [Related]
8. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection? Ben-David D; Novikov I; Mermel LA Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266 [TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation. Moise PA; Culshaw DL; Wong-Beringer A; Bensman J; Lamp KC; Smith WJ; Bauer K; Goff DA; Adamson R; Leuthner K; Virata MD; McKinnell JA; Chaudhry SB; Eskandarian R; Lodise T; Reyes K; Zervos MJ Clin Ther; 2016 Jan; 38(1):16-30. PubMed ID: 26585355 [TBL] [Abstract][Full Text] [Related]
10. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. Burton DC; Edwards JR; Horan TC; Jernigan JA; Fridkin SK JAMA; 2009 Feb; 301(7):727-36. PubMed ID: 19224749 [TBL] [Abstract][Full Text] [Related]
11. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. de Kraker ME; Wolkewitz M; Davey PG; Koller W; Berger J; Nagler J; Icket C; Kalenic S; Horvatic J; Seifert H; Kaasch AJ; Paniara O; Argyropoulou A; Bompola M; Smyth E; Skally M; Raglio A; Dumpis U; Kelmere AM; Borg M; Xuereb D; Ghita MC; Noble M; Kolman J; Grabljevec S; Turner D; Lansbury L; Grundmann H; Antimicrob Agents Chemother; 2011 Apr; 55(4):1598-605. PubMed ID: 21220533 [TBL] [Abstract][Full Text] [Related]
15. Dalbavancin Use in Persons Who Use Drugs May Increase Adherence Without Increasing Cost. Russo TA; Ritchie HR; Schimmel JJ; Lorenzo MP J Pharm Technol; 2024 Feb; 40(1):3-9. PubMed ID: 38318254 [No Abstract] [Full Text] [Related]
16. Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea. Park SH; Park C; Yoo JH; Choi SM; Choi JH; Shin HH; Lee DG; Lee S; Kim J; Choi SE; Kwon YM; Shin WS Infect Control Hosp Epidemiol; 2009 Feb; 30(2):146-55. PubMed ID: 19128184 [TBL] [Abstract][Full Text] [Related]
17. Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Zasowski EJ; Trinh TD; Claeys KC; Lagnf AM; Bhatia S; Klinker KP; Veve MP; Estrada SJ; Johns ST; Sawyer AJ; Huang V; LaFrance B; Levine DP; Kaye KS; Davis SL; Rybak MJ Open Forum Infect Dis; 2022 Mar; 9(3):ofab606. PubMed ID: 35146040 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology and clinical characteristics of Staphylococcus aureus bloodstream infections in a tertiary-care center in Mexico City: 2003-2007. Ponce-de-León A; Camacho-Ortiz A; Macías AE; Landín-Larios C; Villanueva-Walbey C; Trinidad-Guerrero D; López-Jácome E; Galindo-Fraga A; Bobadilla-del-Valle M; Sifuentes-Osornio J Rev Invest Clin; 2010; 62(6):553-9. PubMed ID: 21416781 [TBL] [Abstract][Full Text] [Related]
19. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Harbarth S; Rutschmann O; Sudre P; Pittet D Arch Intern Med; 1998 Jan; 158(2):182-9. PubMed ID: 9448557 [TBL] [Abstract][Full Text] [Related]